Skip to main content
. 2021 Aug;32(8):2020–2030. doi: 10.1681/ASN.2020101531

Table 1.

Baseline sample characteristics across TSAT categories

Characteristics TSAT (%) All
≤15 16–20 21–25 26–35 36–45 ≥46
N patients (row %) 926 (18) 1067 (21) 1178 (23) 1408 (27) 428 (8) 138 (3) 5145
Age, yr 71±13 69±13 70±13 69±14 68±14 65±16 69±13
% male 53 56 58 64 69 62 59
% Black 6 6 4 5 6 5 5
BMI, kg/m2 30±7 29±6 29±6 28±6 28±5 27±5 29±6
Comorbidities (%)
 Diabetes 56 50 46 38 36 27 45
 Hypertension 89 89 90 88 86 81 88
 Coronary artery disease 33 32 29 24 23 24 28
 HF 21 17 13 12 11 9 15
 Cerebrovascular disease 13 12 11 10 8 8 11
 Peripheral vascular disease 22 21 19 19 16 12 20
 Other cardiovascular disease 31 25 25 23 20 17 25
 GI bleeding in past year 3 1 1 1 1 0 1
 Lung disease 13 11 9 8 7 10 10
 Cancer 18 17 18 18 19 18 18
 Ulcers/gangrene of extremity 2 2 3 2 2 0 2
 Neurologic disease 3 3 3 4 4 4 3
 Psychiatric disorder 9 10 8 7 8 8 8
Prescriptions
 ESA, % 16 12 11 13 13 26 13
 Iron, IV or oral, % 32 24 18 15 15 15 21
Labs
TSAT, % 12±3 18±1 23±1 29±3 39±3 55±12 24±10
Ferritin, ng/ml 122±160 160±178 189±177 235±219 257±221 444±502 196±214
Hgb, g/dl 11.5±1.8 12.1±1.7 12.3±1.8 12.6±1.8 12.8±1.9 12.4±2.1 12.3±1.8
eGFR, ml/min per 1.73m2 27±10 28±10 28±11 29±11 29±12 30±12 28±11
Albuminuria (%)
 A1 (normal) 28 29 28 28 28 30 28
 A2 (high) 34 33 33 32 32 34 33
 A3 (very high) 28 28 30 30 29 25 29
 A3 (nephrotic) 10 10 9 10 11 11 10
Serum albumin, g/dl 3.9±0.5 4.0±0.5 4.0±0.4 4.0±0.5 4.0±0.5 4.0±0.5 4.0±0.5
White blood cells, 109/L 7.7±2.4 7.3±2.0 7.2±1.9 6.9±2.0 6.8±1.9 6.8±2.5 7.2±2.1

Results reported as % or mean±SD. Albuminuria categories: A1: <30 mg/g creatinine, A2: 30–300 mg/g creatinine, A3 (very high): >300–2000 mg/g creatinine, and A3 (nephrotic): >2000 mg/g creatinine.